Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Proposed Modification of Dispensing Restrictions for Buprenorphine and Buprenorphine Combination as Used in Approved Opioid Treatment Medications; Correction

This document was released on June 28, 2015 by the U.S. Department of Health and Human Services (HHS) to modify dispensing requirements for take home doses of buprenorphine and buprenorphine combination products approved by the Food and Drug Administration for opioid dependence and used in federally certified and registered opioid treatment programs. The document corrects a previously issued rule to insert omitted details . . .